KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

ACETAB 25 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

25 MG

 

GENERIC NAME:

CAPTOPRIL

 

MANUFACTURER:

KSPICO

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

C

 

INDICATIONS:

Nephropathy, diabetic

Heart failure, congestive

Hypertension, essential

 

SIDE EFFECTS:

agranulocytosis

anaphylactoid reactions

angina

angioedema

cholestasis

cough

dizziness

dysgeusia

fatigue

flushing

glomerulonephritis

hepatic failure

hepatic necrosis

hepatitis

hyperkalemia

hypotension

interstitial nephritis

jaundice

maculopapular rash

metallic taste

nephrotic syndrome

neutropenia

orthostatic hypotension

palpitations

photosensitivity

renal tubular necrosis

sinus tachycardia

syncope

teratogenesis

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

aortic stenosis

autoimmune disease

black patients

bone marrow suppression

breast-feeding

cardiomyopathy

cerebrovascular disease

children

collagen-vascular disease

coronary artery disease

dialysis

elderly

heart failure

hyperkalemia

hyponatremia

hypotension

hypovolemia

immunosuppression

infants

low-density lipoprotein apheresis

neonates

pregnancy

renal artery stenosis

renal disease

renal failure

 

ADULT DOSE:

Antihypertensive-Initial: Oral, 25 mg two or three times a day, the dosage being increased if necessary after one or two weeks to 50 mg two or three times a day. Left ventricular dysfunction following myocardial infarction-Initial: Oral, a single dose of 6.25 mg. Then 12.5 mg three times a day, gradually increased to 25 mg three times a day over several days. Maintenance: Oral, 50 mg three times a day. Note: Captopril therapy may be initiated as early as three days following a myocardial infarction. Diabetic nephropathy-Oral, 25 mg three times a day. Vasodilator, congestive heart failure -Initial: Oral, 25 mg two or three times a day, the dosage being increased gradually as necessary on a daily basis up to 50 mg two or three times a day. If further increases in dosage are needed, it is recommended that they be made after an interval of two weeks so that the full effects of captopril will be apparent. Maintenance: Oral, 50 to 100 mg two or three times a day. Note: An initial dose of 6.25 to 12.5 mg two or three times a day should be used in patients who are sodium- and water-depleted as a result of diuretic therapy, in patients continuing to receive diuretic therapy, or in patients with renal function impairment. Such patients should be kept under medical supervision for one hour after this initial dose, to watch for excessive hypotension . Dosage increases in patients with significant renal function impairment should proceed slowly (one- to two-week intervals), and smaller increments should be used.

 

MAXIMUM ADULT DOSE:

150 mg per day for hypertension and left ventricular dysfunction, post-myocardial infarction. 450 mg per day for congestive heart failure.

 

PEDIATRIC DOSE:

Newborns- Initial: Oral, 10 mcg (0.01 mg) per kg of body weight two or three times a day, the dosage being adjusted as needed and tolerated. Children- Initial: Oral, 300 mcg (0.3 mg) per kg of body weight three times a day, the dosage being increased if necessary in increments of 300 mcg (0.3 mg) per kg of body weight, at intervals of eight to twenty-four hours to the minimum effective dose. Note: An initial dose of 150 mcg (0.15 mg) per kg of body weight three times a day should be used in patients who are sodium- and water-depleted as a result of diuretic therapy, in patients continuing to receive diuretic therapy, and in patients with renal function impairment. 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT